Page last updated: 2024-08-24

pinocembrin and Colitis Gravis

pinocembrin has been researched along with Colitis Gravis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Dou, W; Luo, X; Mani, S; Ren, J; Ren, Y; Wang, Z; Yu, Z; Yue, B; Zhang, J	1

Other Studies

1 other study(ies) available for pinocembrin and Colitis Gravis

Article	Year
Pinocembrin alleviates ulcerative colitis in mice via regulating gut microbiota, suppressing TLR4/MD2/NF-κB pathway and promoting intestinal barrier. Bioscience reports, 2020, 07-31, Volume: 40, Issue:7 Topics: Animals; Caco-2 Cells; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Dose-Response Relationship, Drug; Dysbiosis; Flavanones; Gastrointestinal Microbiome; Humans; Intestinal Mucosa; Lymphocyte Antigen 96; Mice; NF-kappa B; RAW 264.7 Cells; Signal Transduction; Tight Junctions; Toll-Like Receptor 4	2020

Article

Year

Pinocembrin alleviates ulcerative colitis in mice via regulating gut microbiota, suppressing TLR4/MD2/NF-κB pathway and promoting intestinal barrier.

Bioscience reports, 2020, 07-31, Volume: 40, Issue:7

Topics: Animals; Caco-2 Cells; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Dose-Response Relationship, Drug; Dysbiosis; Flavanones; Gastrointestinal Microbiome; Humans; Intestinal Mucosa; Lymphocyte Antigen 96; Mice; NF-kappa B; RAW 264.7 Cells; Signal Transduction; Tight Junctions; Toll-Like Receptor 4

2020